A study published in Gastroenterology reports that a blood test-based scoring tool can help identify previously undiagnosed ...

Background Metabolic dysfunction associated steatotic liver disease (MASLD), the most common chronic liver disease globally, may originate early in life. While maternal obesity is linked to offspring ...

ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency ...

A new blood test can help the early identification of liver scarring in liver disease. Learn more about this study.

Higher TSH levels and lower T3 levels may predict liver outcomes and % MACE risk among individuals with MASLD.

MASLD is present in over 70% of outpatients with type 2 diabetes. In addition, a 2-tier screening approach is useful for liver fibrosis stratification.

Advanced hepatic fibrosis is associated with a significantly higher risk for heart failure with preserved ejection fraction (HFpEF).

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...

TORONTO, ON, CANADA, February 5, 2026 /EINPresswire.com/ — The Fatty Liver Alliance, a liver health-focused Canadian charity, today announced the opening of the ...